To ask Her Majesty's Government, further to the Written Answer by Lord Ahmad of Wimbledon on 18 June (HL5354) which outlined potential delays to “the provision of goods to Syria's pharmaceutical industry”, what steps they are taking to mitigate (1) any damage to that country’s ability to deal with the COVID-19 pandemic, and (2) any impact of sanctions on Syrian civilians.
10 July 2020
The UK is working closely with the UN and our humanitarian partners to respond to the outbreak of COVID-19 in Syria and sustain life-saving services there. On 30 June, the International Development Secretary announced a UK pledge of at least £300 million for the Syria crisis in 2020. The funding will help stop the spread of the virus in Syria by supporting health workers with training, medical supplies and sanitation.
As previously stated in my Written Answer (HL5354), medical equipment and medicines required to fight the COVID-19 pandemic are not subject to direct restrictions on export, supply, financing or use in Syria.